Order Article Reprints

Colarusso A, Maroccia Z, Parrilli E, Germinario EAP, Fortuna A, Loizzo S, Ricceri L, Tutino ML, Fiorentini C, Fabbri A. Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma. Toxins. 2020; 12(5):291. https://doi.org/10.3390/toxins12050291

Colarusso, Andrea, Zaira Maroccia, Ermenegilda Parrilli, Elena Angela Pia Germinario, Andrea Fortuna, Stefano Loizzo, Laura Ricceri, Maria Luisa Tutino, Carla Fiorentini, and Alessia Fabbri. 2020. "Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma" Toxins 12, no. 5: 291. https://doi.org/10.3390/toxins12050291

Colarusso, A., Maroccia, Z., Parrilli, E., Germinario, E. A. P., Fortuna, A., Loizzo, S., Ricceri, L., Tutino, M. L., Fiorentini, C., & Fabbri, A. (2020). Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma. Toxins, 12(5), 291. https://doi.org/10.3390/toxins12050291